Parkside Financial Bank & Trust Cytokinetics Inc Transaction History

Parkside Financial Bank & Trust

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$26.88 - $83.49 $6,988 - $21,707	-260 Reduced 92.2%	22 $1,000
Q3 2023 Nov 13, 2023	BUY	$29.46 - $36.61 $206 - $256	7 Added 2.55%	282 $8,000
Q3 2021 Oct 29, 2021	BUY	$18.54 - $35.74 $982 - $1,894	53 Added 23.87%	275 $10,000
Q4 2020 Feb 09, 2021	BUY	$15.26 - $28.61 $2,258 - $4,234	148 Added 200.0%	222 $5,000
Q2 2019 Aug 06, 2019	BUY	$7.95 - $11.25 $588 - $832	74 New	74 $1,000
Q1 2019 May 01, 2019	SELL	$5.95 - $10.19 $452 - $774	-76 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$5.91 - $9.29 $449 - $706	76 New	76 $0
Q3 2018 Oct 12, 2018	SELL	$6.4 - $9.85 $281 - $433	-44 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$6.9 - $9.9 $165 - $237	-24 Reduced 35.29%	44 $0
Q1 2018 May 02, 2018	BUY	$7.2 - $10.05 $489 - $683	68 New	68 $0
Q4 2017 Feb 05, 2018	SELL	$7.25 - $15.65 $101 - $219	-14 Closed	0 $0
Q3 2017 Oct 27, 2017	BUY	$12.0 - $15.0 $168 - $210	14	14 $0

404

126M

3.24M

2.14M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.35B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Parkside Financial Bank & Trust with notifications on news.